100308/Wellcome Trust/United Kingdom[Grant Number] - Search Results

Year	Number of Results
2013	1
2014	3
2015	2
2016	3
2017	1
2022	0

1

Dendrou CA, Fugger L, Friese MA. Dendrou CA, et al. Nat Rev Immunol. 2015 Sep 15;15(9):545-58. doi: 10.1038/nri3871. Epub 2015 Aug 7. Nat Rev Immunol. 2015. PMID: 26250739 Review.

2

Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.

Friese MA, Schattling B, Fugger L. Friese MA, et al. Nat Rev Neurol. 2014 Apr;10(4):225-38. doi: 10.1038/nrneurol.2014.37. Epub 2014 Mar 18. Nat Rev Neurol. 2014. PMID: 24638138 Review.

3

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.

Dendrou CA, Cortes A, Shipman L, Evans HG, Attfield KE, Jostins L, Barber T, Kaur G, Kuttikkatte SB, Leach OA, Desel C, Faergeman SL, Cheeseman J, Neville MJ, Sawcer S, Compston A, Johnson AR, Everett C, Bell JI, Karpe F, Ultsch M, Eigenbrot C, McVean G, Fugger L. Dendrou CA, et al. Sci Transl Med. 2016 Nov 2;8(363):363ra149. doi: 10.1126/scitranslmed.aag1974. Sci Transl Med. 2016. PMID: 27807284 Free PMC article.

4

Neuroinflammation - using big data to inform clinical practice.

Dendrou CA, McVean G, Fugger L. Dendrou CA, et al. Nat Rev Neurol. 2016 Dec;12(12):685-698. doi: 10.1038/nrneurol.2016.171. Epub 2016 Nov 18. Nat Rev Neurol. 2016. PMID: 27857124 Review.

5

Multiple sclerosis: insights into pathophysiology and novel therapeutic avenues.

Gold R, Fugger L. Gold R, et al. Exp Neurol. 2014 Dec;262 Pt A:1. doi: 10.1016/j.expneurol.2014.04.012. Epub 2014 Apr 18. Exp Neurol. 2014. PMID: 24751800 No abstract available.

6

Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy.

Haghikia A, Dendrou CA, Schneider R, Grüter T, Postert T, Matzke M, Stephanik H, Fugger L, Gold R. Haghikia A, et al. Lancet Neurol. 2017 Feb;16(2):104-106. doi: 10.1016/S1474-4422(16)30382-9. Lancet Neurol. 2017. PMID: 28102146 No abstract available.

7

Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination.

Grodeland G, Fredriksen AB, Løset GÅ, Vikse E, Fugger L, Bogen B. Grodeland G, et al. J Immunol. 2016 Nov 1;197(9):3575-3585. doi: 10.4049/jimmunol.1600893. Epub 2016 Sep 26. J Immunol. 2016. PMID: 27671110 Free PMC article.

8

Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.

Dendrou CA, Fugger L. Dendrou CA, et al. Neuron. 2014 Dec 17;84(6):1105-7. doi: 10.1016/j.neuron.2014.12.012. Neuron. 2014. PMID: 25521369 Free article.

9

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.

McKee JB, Elston J, Evangelou N, Gerry S, Fugger L, Kennard C, Kong Y, Palace J, Craner M. McKee JB, et al. BMJ Open. 2015 Nov 9;5(11):e009200. doi: 10.1136/bmjopen-2015-009200. BMJ Open. 2015. PMID: 26553836 Free PMC article. Clinical Trial.

10

Weighing in on autoimmune disease: Big data tip the scale.

Dendrou CA, Bell JI, Fugger L. Dendrou CA, et al. Nat Med. 2013 Feb;19(2):138-9. doi: 10.1038/nm.3087. Nat Med. 2013. PMID: 23389608 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results